• 1
    Warren JR & Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 12731273.
  • 2
    Murray CJL & Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997; 349: 1498 504.
  • 3
    Pounder RE & Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995; 9(Suppl. 2): 33 9.
  • 4
    Goodwin CS, Mendall MM, Northfield TC. Helicobacter pylori infection. Lancet 1997; 349: 265 9.
  • 5
    NIH Consensus Development Panel. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65 9.
  • 6
    IARC Working Group. Monographs on the evaluation of the carcinogenic risks to humans: schistosomes, liver flukes and Helicobacter pylori. IARC Publications, Geneva, 1994, 177 241.
  • 7
    Webb PM & Forman D. Helicobacter pylori as a risk factor for cancer. Balliere’s Clin Gastroenterol 1996; 9: 563 82.
  • 8
    Crespi M & Citarda F. Helicobacter pylori and gastric cancer: an overrated risk? Scand J Gastroenterol 1996; 31: 1041 6.
  • 9
    Archimandritis A, Bitsakas J, Tjivras M, et al. Non-cardia gastric adenocarcinoma and Helicobacter pylori infection. Ital J Gastroenterol 1993; 25: 368 71.
  • 10
    Asaka M, Kimura T, Kato M, et al. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 1994; 73: 2691 4.
  • 11
    Asaka M, Kato M, Kudo M, et al. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population. Eur J Gastroenterol Hepatol 1995; 7(Suppl. 1): S7 10.
  • 12
    Kikuchi S, Wada O, Nakajima T, et al. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer 1995; 75: 2789 93.
  • 13
    Li D, Gao X, Guan H. Relationship between Helicobacter pylori infection and diffuse and intestinal types of stomach cancer. Chung Hua Liu 1995; 16: 299 302.
  • 14
    Estevens J, Fidalgo P, Tendeiro T, et al. Anti-Helicobacter pylori antibodies: prevalence and gastric adenocarcinoma in Portugal: report of a case-control study. Eur J Cancer Prev 1993; 2: 377 80.
  • 15
    Miglio F, Miglioli M, Holton J, et al. Prevalence of Helicobacter pylori in patients with gastric carcinoma. Irish J Med Sci 1992; 161(Suppl. 10): GCE 37GCE 37(Abstract).
  • 16
    Kang HC & Chung IS. Helicobacter pylori infection and gastric adenocarcinoma in Korea: prevalence and distribution of H. pylori in resected specimen of gastric cancer. J Cath Med Coll 1992; 45: 849 63.
  • 17
    Menegatti M, Vaira D, Miglioli M, et al. Helicobacter pylori in patients with gastric and nongastric cancer. Am J Gastroenterol 1995; 90: 1278 81.
  • 18
    Kurtenkov O, Klaamas K, Cavacci A, Wadstrom T. IgG immune response to a recombinant fragment of cagA in patients with gastric cancer: relation to the ABO(h) blood group phenotype and the stage of cancer. Gut 1997; 41(Suppl. 1): A48A48(Abstract).
  • 19
    Lin JT, Wang JT, Wu MS, Huang SC, Wang TH. Serum levels of pepsinogen I and gastrin in gastric carcinoma: the influence of Helicobacter pylori infection and tumor characteristics. Hepatogastroenterology 1993; 40: 600 3.
  • 20
    Hansson LE, Engstrand L, Nyren O, et al. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993; 105: 1098 103.
  • 21
    Talley NJ, Zinsmeister AR, Weaver A, et al. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83: 1734 9.
  • 22
    Rudi J, Muller M, Von Herbay A, et al. Lack of association of Helicobacter pylori seroprevalence and gastric cancer in a population with low gastric cancer incidence. Scand J Gastroenterol 1995; 30: 958 63.
  • 23
    Rudi J, Kolb C, Maiwald M, et al. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci 1997; 42: 1652 9.
  • 24
    Barreto-Zuniga R, Maruyama M, Kato Y, et al. Significance of Helicobacter pylori infection as a risk factor in gastric cancer: serological and histological studies. J Gastroenterol 1997; 32: 289 94.
  • 25
    Sipponen P, Kosunen TU, Valle J, Rihela M, Seppala K. Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 1992; 45: 319 23.
  • 26
    Blaser MJ, Kobayashi K, Cover TL, Cao P, Feurer ID, Perez-Perez GI. Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach. Int J Cancer 1993; 55: 799 802.
  • 27
    Fukuda H, Saito D, Hayashi S, et al. Helicobacter pylori infection, serum pepsinogen level and gastric cancer: a case-control study in Japan. Jpn J Cancer Res 1995; 86: 64 71.
  • 28
    Chira C, Rovinaru I, Pop F, Raducan L, Copaci I, Vadan R. Gastric cancer and Helicobacter pylori infection. Gut 1996; 39(Suppl. 3): A68A68(Abstract).
  • 29
    Kuipers EJ, Gracia-Casanova M, Pena AS, et al. Helicobacter pylori serology in patients with gastric carcinoma. Scand J Gastroenterol 1993; 28: 433 7.
  • 30
    Kato S, Onda M, Matsukura N, et al. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. Cancer 1996; 77: 1654 61.
  • 31
    Ng TM, Fock KM, Khim MM, et al. Gastric cancer and H. pylori infection in Singapore: lack of association with cagA status. Gut 1997; 41(Suppl. 1): A47A47(Abstract).
  • 32
    Lin JT, Wang JT, Wang TH, Wu MS, Lee TK, Chen CJ. Helicobacter pylori infection in a randomly selected population, healthy volunteers, and patients with gastric ulcer and gastric adenocarcinoma. Scand J Gastroenterol 1993; 28: 1067 72.
  • 33
    Igarashi H, Takahashi S, Ishiyama N, et al. Is Helicobacter pylori a causal agent in gastric carcinoma? Irish J Med Sci 1992; 161(Suppl. 10): GCE 36GCE 36(Abstract).
  • 34
    Fiocca R, Luinetti O, Villani L, et al. High incidence of Helicobacter pylori colonization in early gastric cancer and the possible relationship to carcinogenesis. Eur J Gastroenterol Hepatol 1993; 5(Suppl. 2): S2 8.
  • 35
    Loffeld Rjfl, Willems I, Flendrig JA, Arends JW. Helicobacter pylori and gastric carcinoma. Histopathology 1990; 17: 537 41.
  • 36
    Kokkola A, Valle J, Haapainen R, Sipponen P, Kivilaakso E, Puolakkainen P. Helicobacter pylori infection in young patients with gastric carcinoma. Scand J Gastroenterol 1996; 31: 643 7.
  • 37
    Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type adenocarcinomas. J Natl Cancer Inst 1991; 83: 640 3.
  • 38
    Boixeda D, Gisbdert JP, Arocena C, Baleriola I, Martin de Argila C, Garcia Plaza A. Prevalencia de la infeccion por Helicobacter pylori en el adenocarcinoma gastrico y en la gastritis cronica. Rev Esp Enf Digest 1996; 88: 403 8.
  • 39
    Craanen ME, Blok P, Dekker W, Tytgat GN. Helicobacter pylori and early gastric cancer. Gut 1994; 35: 1372 4.
  • 40
    Shimoyama T, Fukuda S, Tanaka M, Mikami T, Saito Y, Munakata A. High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients. Scand J Gastroenterol 1997; 32: 465 8.
  • 41
    Tokumaru K, Kojima T, Satoh K, et al. CagA gene of Helicobacter pylori is a not a carcinogenic marker in Japanese patients. Gut 1997; 41(Suppl. 1): A47A47(Abstract).
  • 42
    Kim HY, Cho BD, Chang WK, et al. Helicobacter pylori infection and the risk of gastric cancer among the Korean population. J Gastroenterol Hepatol 1997; 12: 100 3.
  • 43
    Webb PM, Yu MC, Forman D, et al. An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China. Int J Cancer 1996; 67: 603 7.
  • 44
    Aromaa A, Kosunen TU, Knekt P, et al. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol 1996; 144: 142 9.
  • 45
    Lin JT, Wang LY, Wang JT, Wang TH, Yang CS, Chen CJ. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer in a cohort of 9775 men in Taiwan. Anticancer Res 1995; 15: 603 6.
  • 46
    Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991; 302: 1302 5.
  • 47
    Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori and mortality from ischaemic heart disease: a negative result from a large prospective study. Br Med J 1997; 315: 1199 201.
  • 48
    Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127 31.
  • 49
    Hansen S, Vollset SE, Melby K, Jellum E. Strong association of previous Helicobacter pylori infection to distal gastric adenocarcinoma. Am J Gastroenterol 1994; 89: A1358A1358(Abstract).
  • 50
    Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132 6.
  • 51
    Siman JH, Forsgren A, Floren CH. Association between Helicobacter pylori and gastric carcinoma in the city of Malmo, Sweden—a prospective study . Gut 1997; 41(Suppl. 1): A45A45(Abstract).
  • 52
    Watanabe Y, Kurata JH, Mizuno S, et al. Helicobacter pylori infection and gastric cancer: a nested case-control study in a rural area of Japan. Dig Dis Sci 1998; 42: 1383 7.
  • 53
    Tulinius H, Ogmundsdottir H, Kristinsson KG, Tryggvadottir L, Jonasson I, Sigfusson N. A retrospective case-control study of H. pylori infection and subsequent gastric cancer in Iceland. IACR Annual Meeting, November 1997, abstract.
  • 54
    Mitchell HM, Hazell SL, Li YY, Hu PJ. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol 1996; 91: 1785 8.
  • 55
    Huang JQ, Sridhar S, Chen Y, Hunt R. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114: 1169 79.
  • 56
    Easterbrook P, Berlin J, Gopalan R, Matthews D. Publication bias in clinical research. Lancet 1991; 337: 867 72.
  • 57
    Feldman RA & Evans SJW. Accuracy of diagnostic methods used for epidemiological studies of Helicobacter pylori. Aliment Pharmacol Ther 1995; 9(Suppl. 2): 21 31.
  • 58
    Rosenstock SJ, Andersen LP, Bonnevie O, Jorgensen T. Sero-conversion and sero-reversion in IgG antibodies to H. pylori: an 11-year follow-up of 2,523 randomly selected Danes . Gut 1996; 39(Suppl. 3): A3A3(Abstract).
  • 59
    Munoz N. Is Helicobacter pylori a cause of gastric cancer? An appraisal of the seroepidemiological evidence. Cancer Epidemiol, Biomarkers Prevention 1994; 3: 445 51.
  • 60
    Blaser MJ, Perez-Perez GI, Kleanthous H. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111 15.
  • 61
    Forman D. Lessons from ongoing intervention studies. In: Hunt R, Tytgat G, eds. Helicobacter pylori: Basic Mechanisms to Clinical Cure. Amsterdam: Kluwer Academic Publishers, 1998.
  • 62
    Danesh J, Forman D, Collins R, Peto R. Helicobacter pylori screening and gastric cancer. Lancet 1996; 348: 758 9.
  • 63
    Peto R. General reflections on principles and purposes: indirect and direct purposes of the present monograph. In: Junshi C, Campbell TC, Junyao L, Peto R, eds. Diet, Life-Style and Mortality in China: a Study of the Characteristics of 65 Chinese Counties. Oxford: Oxford University Press, 1990: 72–8.
  • 64
    Swerdlow AJ, Dos Santos Silva I, Reid A, Qiao Z, Brewster DH, Arrundale J. Trends in cancer incidence and mortality in Scotland. Br J Cancer 1998; 77(Suppl. 3): 1 16.
  • 65
    Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986; 8: 1 27.